826
|
Xu W, Cai J, Li S, Zhang H, Han J, Wen M, Wen J, Gao F. Improving the in vivo persistence, distribution and function of cytotoxic T lymphocytes by inhibiting the tumor immunosuppressive microenvironment. Scand J Immunol 2013; 78:50-60. [PMID: 23659474 DOI: 10.1111/sji.12065] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2012] [Accepted: 04/12/2013] [Indexed: 11/30/2022]
Abstract
Adoptive cell transfer immunotherapy of malignant tumors has the problem of symbiosis between effector cells and tumor cells, a short in vivo residence time, and a poor killing efficiency of effector cells. Thus, releasing effector cells from the cancer immunosuppressive microenvironment and improving their effective time and functional status in vivo would seem to be ideal strategies for facilitating immunotherapy. Low-dose cyclophosphamide administration can effectively break immunotolerance by inhibiting regulatory T cells. In the present study, in order to verify whether the persistence, distribution and function of effector cells can be improved by inhibiting immunosuppressive microenvironment, low-dose cyclophosphamide was previously intraperitoneally injected into melanoma-bearing C57BL/6 mice, thereafter, CFSE-labeled cytotoxic T lymphocytes were transfused intravenously, and their effective time, distributive pattern, and killing efficiency in different groups were observed by measuring the fluorescence intensity and cell cycle of cytotoxic T lymphocytes distributed in various organs, in comparison with tumor growth. We found down-regulating Tregs in vivo can simultaneously reduce the levels of interleukin-10 and transforming growth factor-β. Migration and distribution of cytotoxic T lymphocytes in vivo was found to vary with time. Inhibition of immunotolerance can significantly improve the persistence, distribution, and function of cytotoxic T lymphocytes. Correspondingly, significantly higher secretion of perforin, granzyme B, IL-2, and IFN-γ in tumor tissues with decreased tumor growth was seen in the cyclophosphamide injection group than in the control group. Our study may provide useful information on the cyclophosphamide-mediated mechanism for facilitating tumor immunotherapy by inhibiting the immunosuppressive tumor microenvironment.
Collapse
|
827
|
Wei L, Gao YJ, Wei SP, Zhang YF, Zhang WF, Jiang JX, Sun ZY, Xu W. Transcriptome network-based method to identify genes associated with unruptured intracranial aneurysms. GENETICS AND MOLECULAR RESEARCH 2013; 12:3263-73. [PMID: 24065667 DOI: 10.4238/2013.september.3.2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Intracranial aneurysm is a balloon or sac-like dilatation of blood vessels inside the brain. Despite their importance, the biological mechanisms of intracranial aneurysms are not totally understood. We used public genome-wide gene expression profile data to identify potential genes that are involved in intracranial aneurysm in order to construct a regulation network. Some of the transcription factors and target genes that we identified in this network had been identified as related to intracranial aneurysm in previous studies. We found additional transcription factors and target genes that are apparently related to intracranial aneurysm with this method. The confirmation of previously identified genes and transcription factors supports the usefulness of this transcriptome network analysis for the identification of candidate genes involved in intracranial aneurysm.
Collapse
|
828
|
Guo L, Xue TY, Xu W, Gao JZ. Matrine promotes G0/G1 arrest and down-regulates cyclin D1 expression in human rhabdomyosarcoma cells. Panminerva Med 2013; 55:291-296. [PMID: 24088803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Matrine has a broad-spectrum of anti-cancer effects and is efficient in the inhibition of proliferation of hepatoma cells, leukemia cells and neuroblastoma cell. However, its efficacy and tentative mechanisms in rhabdomyosarcoma have not been addressed before. This study aimed to investigate the effects of Matrine on cell cycle and expression of cyclin D1 in human rhabdomyosarcoma cells (RD cell line). RD cell line was treated with different concentrations (0, 0.5, 1.0, and 1.5 mg/mL) of Matrine, and cell proliferation and cell cycle were evaluated using, respectively, MTT assay and flow cytometry. The effect of Matrine on cyclin D1 mRNA levels was measured by RT-PCR. There was a dose-dependent inhibition of proliferation in the matrine-treated group (inhibition of proliferation rate in control cells 12.70 ± 0.35%; Matrine-treated cells [0.5, 1.0, and 1.5 mg/mL]: 31.16 ± 0.11%, 42.96 ± 0.9%, and 57.26 ± 0.8%). The G0 / G1 ratio in study groups were, respectively, 58.44 ± 3.57%, 64.79 ± 2.03%, 69.97 ± 2.89% and 75.03 ± 1.23%.Cyclin D1 mRNA levels progressively diminished (control group ratio of cyclin D1 / β-actin: 0.59 ± 0.06; Matrine: 0.35 ± 0.05, 0.27 ± 0.02 and 0.04 ± 0.03). All aforementioned changes were significant (P<0.05). In conclusion, Matrine markedly suppresses cell proliferation in RD cells by decreasing expression of cyclin D1 mRNA and blocking the cell cycle at the G0 / G1 stage.
Collapse
|
829
|
Bernstein CN, Ryan JD, Graff LA, Xu W. Commentary: predicting complicated Crohn's disease and surgery--phenotypes, genetics, serology and psychological characteristics of a population-based cohort--authors' reply. Aliment Pharmacol Ther 2013; 38:556-7. [PMID: 23937465 DOI: 10.1111/apt.12423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2013] [Accepted: 07/01/2013] [Indexed: 12/29/2022]
|
830
|
Yao B, Chen X, Shen FX, Xu W, Dong TT, Chen LZ, Weng JP. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. Transplant Proc 2013; 45:194-6. [PMID: 23375298 DOI: 10.1016/j.transproceed.2012.08.019] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2009] [Revised: 06/20/2012] [Accepted: 08/28/2012] [Indexed: 01/28/2023]
Abstract
BACKGROUND Posttransplantation diabetes mellitus (PTDM) is a common, serious complication of kidney transplantation. The purpose of this study was to investigate the incidence of and risk factors for PTDM in relationship to Fok1 vitamin D receptor (VDR) polymorphisms. METHODS One hundred five kidney transplant recipients with normal glucose values before transplantation were recruited for this study. All patients underwent fasting plasma glucose (FPG) determinations followed by oral glucose tolerance tests (OGTTs) among normal FPG recipients. Every recipient underwent Fok1 VDR polymorphism analysis using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). RESULTS Among 105 recipients, 16 (15.24%) developed new-onset PTDM within 6 months after kidney transplantation. Compared with 89 non-PTDM recipients, the mean age was significantly higher among recipients with PTDM: 47.81 ± 15.54 vs 36.62 ± 11.43 years (P = .001). Patients treated with tacrolimus were more susceptible to PTDM (56.25% vs 28.09%; P = .027). The distribution frequencies of Fok1 genotypes in this cohort followed the Hardy-Weinberg equilibrium. The frequencies of 3 genotypes (FF/Ff/ff; P = .040) and 2 alleles (F/f; P = .009) differed between the 2 groups. Multivariate analysis by logistic regression showed age older than 40 years (odds ratio, 7.774; P = .005), VDR Fok1 f allele (odds ratio, 11.765; P = .012), and tacrolimus therapy (odds ratio, 7.499; P = .007) to be related to the development of PTDM. CONCLUSIONS The incidence of newly diagnosed PTDM in this study was 15.24%. Fok1 VDR polymorphism was a genetic marker predicting PTDM risk. Age older than 40 years and tacrolimus were independent risk factors for PTDM.
Collapse
|
831
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Alford J, Anson CD, Aparin A, Arkhipkin D, Aschenauer E, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bhattarai P, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bültmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chang Z, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Das S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, di Ruzza B, Didenko L, Ding F, Dion A, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fazio S, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Flores E, Gagliardi CA, Gangadharan DR, Garand D, Geurts F, Gibson A, Gliske S, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Igo G, Jacobs WW, Jena C, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kikola DP, Kiryluk J, Kisel I, Kisiel A, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kulakov I, Kumar L, Lamont MAC, Landgraf JM, Landry KD, Lapointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nelson JM, Nogach LV, Novak J, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Poljak N, Porter J, Poskanzer AM, Powell CB, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Ramachandran S, Raniwala R, Raniwala S, Ray RL, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Ruan L, Rusnak J, Sahoo NR, Sahu PK, Sakrejda I, Salur S, Sandacz A, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke B, Schmitz N, Schuster TR, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, Desouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi L, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y, Zyzak M. Measurement of J/ψ azimuthal anisotropy in Au+Au collisions at sqrt[s(NN)]=200 GeV. PHYSICAL REVIEW LETTERS 2013; 111:052301. [PMID: 23952389 DOI: 10.1103/physrevlett.111.052301] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2012] [Revised: 05/10/2013] [Indexed: 06/02/2023]
Abstract
The measurement of J/ψ azimuthal anisotropy is presented as a function of transverse momentum for different centralities in Au+Au collisions at sqrt[s(NN)]=200 GeV. The measured J/ψ elliptic flow is consistent with zero within errors for transverse momentum between 2 and 10 GeV/c. Our measurement suggests that J/ψ particles with relatively large transverse momenta are not dominantly produced by coalescence from thermalized charm quarks, when comparing to model calculations.
Collapse
|
832
|
Ryan JD, Silverberg MS, Xu W, Graff LA, Targownik LE, Walker JR, Carr R, Clara I, Miller N, Rogala L, Bernstein CN. Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Aliment Pharmacol Ther 2013; 38:274-83. [PMID: 23725363 DOI: 10.1111/apt.12368] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2013] [Revised: 02/20/2013] [Accepted: 05/16/2013] [Indexed: 12/20/2022]
Abstract
BACKGROUND Predictors of complicated Crohn's disease (CD), defined as stricturing or penetrating behaviour, and surgery have largely been derived from referral centre populations. AIM To investigate whether serological markers, susceptibility genes or psychological characteristics are associated with complicated CD or surgery in a population-based cohort. METHODS One hundred and eighty-two members of the Manitoba IBD Cohort with CD phenotyped using the Montreal classification underwent genetic and serological analysis at enrolment and after 5 years. One hundred and twenty-seven had paired sera at baseline and 5 years later and their data were used to predict outcomes at a median of 9.3 years. Serological analysis consisted of a seven antibody panel, and DNA was tested for CD-associated NOD2 variants (rs2066845,rs2076756,rs2066847), ATG16L1 (rs3828309, rs2241880) and IL23R (rs11465804). Psychological characteristics were assessed using semi-structured interviews and validated survey measures. RESULTS Sixty-five per cent had complicated CD and 42% underwent surgery. Multivariate analysis indicated that only ASCA IgG-positive serology was predictive of stricturing/penetrating behaviour (OR = 3.01; 95% CI: 1.28-7.09; P = 0.01) and ileal CD (OR = 2.2; 95% CI: 1.07-4.54, P = 0.03). Complicated CD behaviour was strongly associated with surgery (OR = 5.6; 95% CI: 2.43-12.91; P < 0.0001), whereas in multivariate analysis, only ASCA IgG was associated (OR = 2.66; 95% CI, 1.40-5.06, P = 0.003). ASCA titre results were similar at baseline and follow-up. Psychological characteristics were not significantly associated with disease behaviour, serological profile or genotype. CONCLUSIONS ASCA IgG at baseline was significantly associated with stricturing/penetrating disease at 9-10 years from diagnosis. Stricturing/penetrating disease was significantly associated with surgery. In a model including serology, the genotypes assessed did not significantly associate with complicated disease or surgery.
Collapse
|
833
|
Bai S, Liu S, Zhang C, Xu W, Lu Q, Han H, Kaplan DL, Zhu H. Controllable transition of silk fibroin nanostructures: an insight into in vitro silk self-assembly process. Acta Biomater 2013; 9:7806-13. [PMID: 23628774 DOI: 10.1016/j.actbio.2013.04.033] [Citation(s) in RCA: 90] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2013] [Revised: 04/15/2013] [Accepted: 04/18/2013] [Indexed: 11/29/2022]
Abstract
Silk fiber is one of the strongest and toughest biological materials with hierarchical structures, where nanofibril with size <20nm is a critical factor in determining its excellent mechanical properties. Although silk nanofibrils have been found in natural and regenerated silk solutions, there is no way to actively control nanofibril formation in aqueous solution. This study shows a simple but effective method of preparing silk nanofibrils by regulating the silk self-assembly process. Through a repeated drying-dissolving process, a silk fibroin solution composed of metastable nanoparticles was first prepared and then used to reassemble nanofibrils with different sizes and secondary conformations under various temperatures and concentrations. These nanofibrils have a similar size to that of natural fibers, providing a suitable unit to further assemble the hierarchical structure in vitro. Several important issues, such as the relationships between silk nanofibrils, secondary conformations and viscosity, are also investigated, giving a new insight into the self-assembly process. In summary, besides rebuilding silk nanofibrils in aqueous solution, this study provides an important model for furthering the understanding of silk structures, properties and forming mechanisms, making it possible to regenerate silk materials with exceptional properties in the future.
Collapse
|
834
|
Alarcon SV, Mollapour M, Lee MJ, Tsutsumi S, Lee S, Kim YS, Prince T, Apolo AB, Giaccone G, Xu W, Neckers LM, Trepel JB. Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy. Curr Mol Med 2013; 12:1125-41. [PMID: 22804236 DOI: 10.2174/156652412803306729] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2012] [Revised: 05/18/2012] [Accepted: 07/07/2012] [Indexed: 01/19/2023]
Abstract
In 1994 the first heat shock protein 90 (Hsp90) inhibitor was identified and Hsp90 was reported to be a target for anticancer therapeutics. In the past 18 years there have been 17 distinct Hsp90 inhibitors entered into clinical trial, and the small molecule Hsp90 inhibitors have been highly valuable as probes of the role of Hsp90 and its client proteins in cancer. Although no Hsp90 inhibitor has achieved regulatory approval, recently there has been significant progress in Hsp90 inhibitor clinical development, and in the past year RECIST responses have been documented in HER2-positive breast cancer and EML4-ALK-positive non-small cell lung cancer. All of the clinical Hsp90 inhibitors studied to date are specific in their target, i.e. they bind exclusively to Hsp90 and two related heat shock proteins. However, Hsp90 inhibitors are markedly pleiotropic, causing degradation of over 200 client proteins and impacting critical multiprotein complexes. Furthermore, it has only recently been appreciated that Hsp90 inhibitors can, paradoxically, cause transient activation of the protein kinase clients they are chaperoning, resulting in initiation of signal transduction and significant physiological events in both tumor and tumor microenvironment. An additional area of recent progress in Hsp90 research is in studies of the posttranslational modifications of Hsp90 itself and Hsp90 co-chaperone proteins. Together, a picture is emerging in which the impact of Hsp90 inhibitors is shaped by the tumor intracellular and extracellular milieu, and in which Hsp90 inhibitors impact tumor and host on a microenvironmental and systems level. Here we review the tumor intrinsic and extrinsic factors that impact the efficacy of small molecules engaging the Hsp90 chaperone machine.
Collapse
|
835
|
Dai Y, Feng Y, Xu R, Xu W, Lu W, Wang J. Erratum to: Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis 2013. [DOI: 10.1007/s10096-013-1834-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
836
|
Xu W, Li YH, Tan BP, Luo XJ, Xiao L, Zheng XG, Yang XY, Sui N. Inhibition of the acquisition of conditioned place aversion by dopaminergic lesions of the central nucleus of the amygdala in morphine-treated rats. Physiol Res 2013; 61:437-42. [PMID: 22985193 DOI: 10.33549/physiolres.932273] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
The negative affective state of opiate abstinence plays an important role in craving and relapse to compulsive drug use. The dopamine system participates in the reward effects of opiate use and the aversive effect of opiate abstinence. The amygdala is an essential neural substrate for associative learning of emotion. To establish a model of conditioned place aversion (CPA) in morphine-treated rats, we used different visual and tactual cues as conditioned stimuli (CS) within a conditioning apparatus. An injection of naloxone served as the unconditioned stimulus (US). The 6-hydroxydopamine (6-OHDA) lesion technique was used to investigate the effects of the dopaminergic system of the central nucleus of the amygdala (CeA) on naloxone-induced CPA. Rats were rendered physically dependent via administration of increasing doses of morphine delivered via intraperitoneal injection. Doses increased by 20 % each day for 14 days, starting from an initial dose of 6 mg/kg. All rats also received a low dose of naloxone (0.1 mg/kg) by injection 4 hours after morphine treatment on days 11 and 13 to induce CPA in a biased two-compartment conditioned place apparatus. Morphine-dependent rats with sham lesions were found to develop significant CPA after naloxone treatment. Bilateral 6-OHDA lesions of the CeA impaired the acquisition of CPA but had no effect on locomotor activity. These results suggest that the dopaminergic system of the CeA plays an important role in the negative affective state of opiate abstinence.
Collapse
|
837
|
Ryan E, DeCroix D, Breault R, Xu W, Huckaby E, Saha K, Dartevelle S, Sun X. Multi-phase CFD modeling of solid sorbent carbon capture system. POWDER TECHNOL 2013. [DOI: 10.1016/j.powtec.2013.01.009] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
838
|
Emery P, Fleischmann R, Hsia E, Xu S, Xu W, Baker D. AB0485 Golimumab’s efficacy in patients with very active disease in methotrexate-naÏve rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
839
|
Ye JX, Shen GS, Zhou HB, Xu W, Xie ZG, Dong QR, Xu YJ. Arthroscopic reconstruction of the anterior cruciate ligament with the LARS artificial ligament: thirty-six to fifty-two months follow-up study. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2013; 17:1438-1446. [PMID: 23771532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
OBJECTIVES This study aims to analyze the operating methods and fundamental clinical effects of the reconstruction of the anterior cruciate ligament (ACL) with the Ligament Advancement Reinforcement System (LARS) artificial ligaments using an arthroscopy. PATIENTS AND METHODS Fifty-three patients with ACL rupture who were treated using LARS artificial ligaments were enrolled in this retrospective study. The mean age at the time of reconstruction was 31.2 y (range, 22-51y). Average time from injury to surgery was 18 d (range, 5-51 d). Average follow-up period was 45 mo (range 36-52 months). Follow-up examinations included the Lysholm Knee Score and the International Knee Documentation Committee (IKDC) score. RESULTS The average Lysholm Knee Score was 53.1±5.8 preoperatively (range, 47-76) versus 93.2±3.4 three years after operation (range, 80-100). Fifty-one of 53 patents (96.2%) showed good or excellent results at final assessment. The final IKDC score 3 years after operation were normal in 28 patients (52.8%), nearly normal in 23 patients (43.4%), and abnormal in 2 patients (3.8%). No postoperative complications, such as infection, ligament rupture, or ligament cinch occurred. CONCLUSIONS The results suggest that LARS artificial ligament appears to be an effective graft for ACL reconstruction leading to good knee function and stability. Long-term follow-up should be performed to confirm the durable stability of the knee and the tolerance of the knee to the LARS artificial ligament.
Collapse
|
840
|
Xu Z, Qi X, Dahl AK, Xu W. Waist-to-height ratio is the best indicator for undiagnosed type 2 diabetes. Diabet Med 2013; 30:e201-7. [PMID: 23444984 DOI: 10.1111/dme.12168] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2012] [Revised: 11/20/2012] [Accepted: 02/20/2013] [Indexed: 10/27/2022]
Abstract
AIMS Early detection of diabetes is important for the prevention of diabetic complications. The best adiposity index for indicating Type 2 diabetes mellitus remains unclear. We aimed to identify the optimal adiposity measure among BMI, waist circumference, waist-hip ratio and waist-to-height ratio to indicate undiagnosed Type 2 diabetes and impaired fasting glucose in Chinese adults. METHODS A total of 7567 participants aged 20-79 years were included in this study. Impaired fasting glucose was defined as a fasting plasma glucose level of 6.1-6.9 mmol/l in participants without diabetes. Undiagnosed Type 2 diabetes was identified as fasting plasma glucose ≥ 7.0 mmol/l when neither a history of diabetes nor use of hypoglycaemic drugs was present. Body weight, height, waist and hip circumferences were measured following standard procedures. Data were analysed using logistic regression and areas under the receiver operating characteristic curves. RESULTS Of the 7567 participants, 536 were defined as having impaired fasting glucose and 690 were patients with Type 2 diabetes, including 290 (3.8%) persons with undiagnosed diabetes. In multivariate logistic regression, the odds ratios of waist-to-height ratio (≥ 0.5) were stronger than BMI (≥ 24 kg/m²), waist circumference (≥ 85 cm in men and ≥ 80 cm in women) and waist-hip ratio (≥ 0.85) for undiagnosed Type 2 diabetes and impaired fasting glucose. Among the four indices, waist-to-height ratio ≥ 0.5 showed the largest area under the receiver operating characteristic curve for diagnosing undiagnosed Type 2 diabetes (0.725, 95% CI 0.693-0.756) and impaired fasting glucose (0.662, 95% CI 0.638-0.687). CONCLUSIONS By comparison with BMI, waist circumference and waist-hip ratio, waist-to-height ratio ≥ 0.5 may be the best indicator for undiagnosed Type 2 diabetes and impaired fasting glucose.
Collapse
|
841
|
Xu W, Zhang R, Xu M, Roeske J. SU-E-T-316: Dosimetry of Electron Beams at Extremely Extended SSD: Monte Carlo Calculations and Measurements. Med Phys 2013. [DOI: 10.1118/1.4814750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
842
|
Xu S, Ge R, Xu W, Cong X, Xie C, Gong H. SU-E-T-155: RapidArc Delivery Performance Using EDR2 Film and EPID Measurement. Med Phys 2013. [DOI: 10.1118/1.4814590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
843
|
Patlolla A, Baumann P, Xu W, Senanayake SD, Rodriguez JA, Frenkel AI. Characterization of Metal-Oxide Catalysts in Operando Conditions by Combining X-ray Absorption and Raman Spectroscopies in the Same Experiment. Top Catal 2013. [DOI: 10.1007/s11244-013-0053-y] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
844
|
Liu W, Li Z, Xu W, Wang Q, Yang S. Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer. Scand J Immunol 2013; 77:255-60. [PMID: 23421499 DOI: 10.1111/sji.12032] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2012] [Accepted: 01/10/2013] [Indexed: 02/01/2023]
Abstract
To understand the autoimmune response and immunogenicity of a tumour-associated antigen (TAA) and IGF2 mRNA-binding protein (IMP2/62) in colon cancer, autoantibody to this TAA was evaluated by enzyme-linked immunosorbent assay (ELISA), Western blotting and indirect immunofluorescence assay in sera from patients with colon cancer. Immunohistochemistry (IHC) study with colon cancer tissues was also performed to analyse protein expression of IMP2/p62. The result has showed that there has a relatively higher frequency of autoantibody response to IMP2/p62 in colon cancer (23.4%, 15/64) compared to patients with colonic adenomas (4.8%, 2/42) and normal individuals (2.9%, 1/34). Of 64 colon cancer tissue specimens examined, 48 tissues (75.0%, 48/64) expressed p62, while normal colon tissues did not show any expression of p62 (0/34). The positive rate of antinuclear antibody (ANA) in colon cancer was 82.8% (53/64), which is significantly higher than that in patients with colonic adenomas (21.4%, 9/42) and normal individuals (17.6%, 6/34). The data suggest that the combinational detection of anti-p62 autoantibody and ANA is of significance in diagnosing colon cancer and monitoring the prognosis of the disease.
Collapse
|
845
|
Xu W, Li Y, Liu C, Zhao S. Protein lysine acetylation guards metabolic homeostasis to fight against cancer. Oncogene 2013; 33:2279-85. [PMID: 23665675 DOI: 10.1038/onc.2013.163] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2012] [Revised: 03/11/2013] [Accepted: 03/12/2013] [Indexed: 02/07/2023]
Abstract
Properly coordinated metabolism and maintained metabolite homeostasis are important because altered metabolite homeostasis has a causal role in many human diseases, including cancer. Metabolite homeostasis is maintained by fine-tuned coordination of metabolite generation and utilization. Metabolite deregulation has recently been shown to alter the signaling pathways and reprogram epigenetic factors associated with tumorigenesis. Protein lysine acetylation is emerging as a metabolism-coordinating mechanism. Mechanistic studies have shown that acetylation may have roles in nutrient adaptation and in maintaining metabolite homeostasis by exerting regulatory effects on metabolic enzymes, metabolic pathways and metabolic networks. Here we review recent progress in the determination of the role of acetylation regulation in metabolism coordination. In particular, we review links between deregulated acetylation in metabolic enzymes and tumorigenesis. We further hypothesize on applications of the mediation of acetylation to restore deregulated metabolism coordination and thus develop novel means of cancer treatment.
Collapse
|
846
|
Sotthivirat S, McKelvey C, Moser J, Rege B, Xu W, Zhang D. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364. Int J Pharm 2013; 452:73-81. [PMID: 23651642 DOI: 10.1016/j.ijpharm.2013.04.037] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Revised: 03/10/2013] [Accepted: 04/15/2013] [Indexed: 11/18/2022]
Abstract
The goal of this study was to demonstrate that MK-0364 solid dispersions can be developed as a means to increase the solubility and bioavailability of a poorly water-soluble drug, MK-0364. The potential solid dispersions would enable an oral solid dosage form as a monotherapy or combination product of MK-0364. Preliminary screening included sample preparation via a solvent casting method, physical characterization, and in vitro dissolution testing. Lead formulations were subsequently manufactured using hot melt extrusion (HME) and spray-drying (SD). All HME (without polyvinyl pyrrolidone) and SD formulations exhibit characteristics of a single phase glass including an amorphous halo when analyzed with X-ray powder diffraction (XRPD), a single glass transition temperature (Tg) measured with differential scanning calorimetry (DSC), and supersaturation when dissolved in dissolution media. The oral absorption of MK-0364 from selected HME and SD formulations in monkeys results in marginally greater exposure with a consistently longer Tmax relative to a liquid filled capsule reference. Based on the processability, physical characterization, in vitro dissolution, and animal pharmacokinetic results, copovidone- and hydroxypropyl methylcellulose acetate succinate (HPMCAS)-based solid dispersion formulations are viable product concepts. The physical stability of both the solid dispersion formulations was also evaluated for 54 weeks under different conditions. The copovidone-based solid dispersion requires protection from moisture.
Collapse
|
847
|
Zhang H, Xu W, Dahl AK, Xu Z, Wang HX, Qi X. Relation of socio-economic status to impaired fasting glucose and Type 2 diabetes: findings based on a large population-based cross-sectional study in Tianjin, China. Diabet Med 2013; 30:e157-62. [PMID: 23397898 DOI: 10.1111/dme.12156] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2012] [Revised: 11/09/2012] [Accepted: 02/05/2013] [Indexed: 11/28/2022]
Abstract
AIMS Studies on the relationship between socio-economic status and Type 2 diabetes mellitus in the Chinese population are sparse. We aimed to examine the relation of socio-economic status as represented by income, education and occupation to impaired fasting glucose, Type 2 diabetes, and the control of Type 2 diabetes in a large Chinese population. METHODS This study included 7315 individuals who were aged 20-79 years and living in Tianjin, China. Impaired fasting glucose and Type 2 diabetes were ascertained according to the 1999 World Health Organization criteria. Data were analysed using multinomial and binary logistic regression, with adjustment for potential confounders. RESULT Among all participants, 532 (7.3%) persons had impaired fasting glucose, 688 (9.4%) persons had Type 2 diabetes, including 288 (3.9%) previously undiagnosed Type 2 diabetes. In fully adjusted multinomial logistic regression, compared with higher income (≥ 2000 yuan, $243.3/month), lower income (< 1000 yuan, $121.70/month) showed odds ratios (95% confidence intervals) of 3.31 (2.48-4.41) for impaired fasting glucose, 4.50 (3.07-6.61) for undiagnosed Type 2 diabetes and 4.56 (3.20-6.48) for diagnosed Type 2 diabetes. These results remained significant in the analysis stratified by education and occupation. Furthermore, persons who were retired were more likely to have impaired fasting glucose [odds ratio 1.91 (1.40-2.45)], undiagnosed Type 2 diabetes [odds ratio 2.01) 1.40-2.89] and diagnosed Type 2 diabetes [odds ratio 3.02 (2.12-4.22)]. Among the patients with Type 2 diabetes previously diagnosed, lower education (less than senior high school), non-manual work and unemployment were related to worse glycaemic control (fasting blood glucose level > 8.5 mmol/l). CONCLUSIONS Lower income and retirement are associated with increased odds of impaired fasting glucose and Type 2 diabetes in Tianjin, China. Education and occupation may play a role in glycaemic control among patients with Type 2 diabetes.
Collapse
|
848
|
Aguilar M, Alberti G, Alpat B, Alvino A, Ambrosi G, Andeen K, Anderhub H, Arruda L, Azzarello P, Bachlechner A, Barao F, Baret B, Barrau A, Barrin L, Bartoloni A, Basara L, Basili A, Batalha L, Bates J, Battiston R, Bazo J, Becker R, Becker U, Behlmann M, Beischer B, Berdugo J, Berges P, Bertucci B, Bigongiari G, Biland A, Bindi V, Bizzaglia S, Boella G, de Boer W, Bollweg K, Bolmont J, Borgia B, Borsini S, Boschini MJ, Boudoul G, Bourquin M, Brun P, Buénerd M, Burger J, Burger W, Cadoux F, Cai XD, Capell M, Casadei D, Casaus J, Cascioli V, Castellini G, Cernuda I, Cervelli F, Chae MJ, Chang YH, Chen AI, Chen CR, Chen H, Cheng GM, Chen HS, Cheng L, Chernoplyiokov N, Chikanian A, Choumilov E, Choutko V, Chung CH, Clark C, Clavero R, Coignet G, Commichau V, Consolandi C, Contin A, Corti C, Costado Dios MT, Coste B, Crespo D, Cui Z, Dai M, Delgado C, Della Torre S, Demirkoz B, Dennett P, Derome L, Di Falco S, Diao XH, Diago A, Djambazov L, Díaz C, von Doetinchem P, Du WJ, Dubois JM, Duperay R, Duranti M, D'Urso D, Egorov A, Eline A, Eppling FJ, Eronen T, van Es J, Esser H, Falvard A, Fiandrini E, Fiasson A, Finch E, Fisher P, Flood K, Foglio R, Fohey M, Fopp S, Fouque N, Galaktionov Y, Gallilee M, Gallin-Martel L, Gallucci G, García B, García J, García-López R, García-Tabares L, Gargiulo C, Gast H, Gebauer I, Gentile S, Gervasi M, Gillard W, Giovacchini F, Girard L, Goglov P, Gong J, Goy-Henningsen C, Grandi D, Graziani M, Grechko A, Gross A, Guerri I, de la Guía C, Guo KH, Habiby M, Haino S, Hauler F, He ZH, Heil M, Heilig J, Hermel R, Hofer H, Huang ZC, Hungerford W, Incagli M, Ionica M, Jacholkowska A, Jang WY, Jinchi H, Jongmanns M, Journet L, Jungermann L, Karpinski W, Kim GN, Kim KS, Kirn T, Kossakowski R, Koulemzine A, Kounina O, Kounine A, Koutsenko V, Krafczyk MS, Laudi E, Laurenti G, Lauritzen C, Lebedev A, Lee MW, Lee SC, Leluc C, León Vargas H, Lepareur V, Li JQ, Li Q, Li TX, Li W, Li ZH, Lipari P, Lin CH, Liu D, Liu H, Lomtadze T, Lu YS, Lucidi S, Lübelsmeyer K, Luo JZ, Lustermann W, Lv S, Madsen J, Majka R, Malinin A, Mañá C, Marín J, Martin T, Martínez G, Masciocchi F, Masi N, Maurin D, McInturff A, McIntyre P, Menchaca-Rocha A, Meng Q, Menichelli M, Mereu I, Millinger M, Mo DC, Molina M, Mott P, Mujunen A, Natale S, Nemeth P, Ni JQ, Nikonov N, Nozzoli F, Nunes P, Obermeier A, Oh S, Oliva A, Palmonari F, Palomares C, Paniccia M, Papi A, Park WH, Pauluzzi M, Pauss F, Pauw A, Pedreschi E, Pensotti S, Pereira R, Perrin E, Pessina G, Pierschel G, Pilo F, Piluso A, Pizzolotto C, Plyaskin V, Pochon J, Pohl M, Poireau V, Porter S, Pouxe J, Putze A, Quadrani L, Qi XN, Rancoita PG, Rapin D, Ren ZL, Ricol JS, Riihonen E, Rodríguez I, Roeser U, Rosier-Lees S, Rossi L, Rozhkov A, Rozza D, Sabellek A, Sagdeev R, Sandweiss J, Santos B, Saouter P, Sarchioni M, Schael S, Schinzel D, Schmanau M, Schwering G, Schulz von Dratzig A, Scolieri G, Seo ES, Shan BS, Shi JY, Shi YM, Siedenburg T, Siedling R, Son D, Spada F, Spinella F, Steuer M, Stiff K, Sun W, Sun WH, Sun XH, Tacconi M, Tang CP, Tang XW, Tang ZC, Tao L, Tassan-Viol J, Ting SCC, Ting SM, Titus C, Tomassetti N, Toral F, Torsti J, Tsai JR, Tutt JC, Ulbricht J, Urban T, Vagelli V, Valente E, Vannini C, Valtonen E, Vargas Trevino M, Vaurynovich S, Vecchi M, Vergain M, Verlaat B, Vescovi C, Vialle JP, Viertel G, Volpini G, Wang D, Wang NH, Wang QL, Wang RS, Wang X, Wang ZX, Wallraff W, Weng ZL, Willenbrock M, Wlochal M, Wu H, Wu KY, Wu ZS, Xiao WJ, Xie S, Xiong RQ, Xin GM, Xu NS, Xu W, Yan Q, Yang J, Yang M, Ye QH, Yi H, Yu YJ, Yu ZQ, Zeissler S, Zhang JG, Zhang Z, Zhang MM, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zuccon P, Zurbach C. First result from the Alpha Magnetic Spectrometer on the International Space Station: precision measurement of the positron fraction in primary cosmic rays of 0.5-350 GeV. PHYSICAL REVIEW LETTERS 2013; 110:141102. [PMID: 25166975 DOI: 10.1103/physrevlett.110.141102] [Citation(s) in RCA: 123] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2013] [Indexed: 06/03/2023]
Abstract
A precision measurement by the Alpha Magnetic Spectrometer on the International Space Station of the positron fraction in primary cosmic rays in the energy range from 0.5 to 350 GeV based on 6.8 × 10(6) positron and electron events is presented. The very accurate data show that the positron fraction is steadily increasing from 10 to ∼ 250 GeV, but, from 20 to 250 GeV, the slope decreases by an order of magnitude. The positron fraction spectrum shows no fine structure, and the positron to electron ratio shows no observable anisotropy. Together, these features show the existence of new physical phenomena.
Collapse
|
849
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Alford J, Anson CD, Aparin A, Arkhipkin D, Aschenauer E, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bhattarai P, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bültmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chang Z, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Das S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, di Ruzza B, Didenko L, Ding F, Dion A, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fazio S, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Flores E, Gagliardi CA, Gangadharan DR, Garand D, Geurts F, Gibson A, Gliske S, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Igo G, Jacobs WW, Jena C, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kikola DP, Kiryluk J, Kisel I, Kisiel A, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kulakov I, Kumar L, Lamont MAC, Landgraf JM, Landry KD, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nelson JM, Nogach LV, Novak J, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Poljak N, Porter J, Poskanzer AM, Powell CB, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Ramachandran S, Raniwala R, Raniwala S, Ray RL, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Ruan L, Rusnak J, Sahoo NR, Sahu PK, Sakrejda I, Salur S, Sandacz A, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke B, Schmitz N, Schuster TR, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi L, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y, Zyzak M. Observation of an energy-dependent difference in elliptic flow between particles and antiparticles in relativistic heavy ion collisions. PHYSICAL REVIEW LETTERS 2013; 110:142301. [PMID: 25166982 DOI: 10.1103/physrevlett.110.142301] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2013] [Indexed: 06/03/2023]
Abstract
Elliptic flow (v(2)) values for identified particles at midrapidity in Au + Au collisions, measured by the STAR experiment in the beam energy scan at RHIC at sqrt[s(NN)] = 7.7-62.4 GeV, are presented. A beam-energy-dependent difference of the values of v(2) between particles and corresponding antiparticles was observed. The difference increases with decreasing beam energy and is larger for baryons compared to mesons. This implies that, at lower energies, particles and antiparticles are not consistent with the universal number-of-constituent-quark scaling of v(2) that was observed at sqrt[s(NN)] = 200 GeV.
Collapse
|
850
|
Xu J, Zhu W, Xu W, Yao W, Zhang B, Xu Y, Ji S, Liu C, Long J, Ni Q, Yu X. Up-Regulation of MBD1 Promotes Pancreatic Cancer Cell Epithelial-Mesenchymal Transition and Invasion by Epigenetic Down-Regulation of E-Cadherin. Curr Mol Med 2013. [DOI: 10.2174/156652413805076740] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|